Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2017

Total Assets: $28.3M

Liabilities Breakdown FY2017

Total Liabilities: $11.5M